CDKN2B and myelodysplastic syndrome: This can also occur in primary leukemic blasts isolated from patients with myelodysplastic syndrome (MDS) and AML [24], and hypermethylation of the p15INK4B promoter is associated with a poor prognosis in MDS and AML [24], [25], [26].